Corbus Barclay 4

What Happened Corbus Barclay, a director of Bed Bath & Beyond, had restricted stock units (RSUs) vest and convert into 26,873 shares on May 15, 2026; those 26,873 shares were reported as both acquired (conversion) and disposed on the same date. Separately, Barclay was granted 35,181 RSUs on May 14, 2026 (these RSUs carry a $0.00 grant price and vest later). The filing also shows 7,816 warrants issued October 7, 2025 (warrant exercise price $15.50).

Key Details

• Transaction dates: RSU grant 5/14/2026 (35,181 RSUs, $0.00 grant price); RSU vest/convert and same‑day disposition 5/15/2026 (26,873 shares; acquisition reported N/A and disposition reported $0.00); earlier pro‑rata warrant distribution 10/07/2025 (7,816 warrants).
• Prices/values: RSU grants reported at $0.00 (typical for restricted awards). Warrants carry a $15.50 exercise price per warrant. The disposed shares are reported with $0.00 value in the filing (reported as a derivative transaction).
• Shares/units remaining after transactions (per filing): 35,181 restricted stock units from the 5/14/2026 grant (vesting 5/14/2027) and 7,816 warrants from the 10/07/2025 distribution. The 26,873 RSUs that vested on 5/15/2026 were converted and reported as disposed on the same date.
• Footnotes: F1 notes the 26,873 RSUs vested at close of business on 5/15/2026 and vested shares are delivered promptly after vesting. F2 notes the 35,181 RSUs vest on 5/14/2027. F3 explains the 7,816 instruments are warrants from a 10/07/2025 pro‑rata distribution (exempt from immediate reporting) exercisable at $15.50 each.
• Filing timeliness: Form 4 was filed 05/18/2026. The filing date is within the usual Section 16 reporting window for these transactions (no late filing indicated).

Context

• These entries involve restricted stock units converting to shares (derivative transactions) and a new RSU grant — common forms of director compensation. The same‑day acquisition and disposition of the 26,873 shares is reported as a derivative exercise/conversion and subsequent disposition in the filing; the disposition is shown at $0.00 in the report. Warrants reported do not reflect an immediate cash purchase — they give the right to buy shares later at $15.50 each. As always, such compensation disclosures are factual reporting of awards and conversions and do not by themselves indicate the insider's view of the company's stock.